Emerging Markets Report: A Cleaner World

ORLANDO, Fla., Nov. 24, 2020 (GLOBE NEWSWIRE) -- We are watching intently, reading, listening to the smartest minds out there… doing anything and everything… to figure out what will forever be changed by the pandemic and also what opportunities will be created for us.

And we believe we’ve identified a few important, critical trends.

We’ve previously discussed how we think e-health and remote visits will forever be the way that some health care is rendered. It just makes so much sense and it’s very convenient for all parties. It’s also clear that mighty Amazon will be a first option for many items that you would previously go to the store for.

But are masks and Personal Protective Equipment (PPE) also the way of the new normal? Will masks and PPE be a part of how we deal with flu epidemics, pollution, pollen, even just the flu season, as we go forward?

And is sanitization in the home, on planes, trains, buses, subways, schools, office buildings, and well, just about everywhere, also the new standard?

Will a mask be as normal a procedure as putting on a jacket when it's cold out? Will a nightly sanitization and disinfectant process at the grocery store be par for the course now?

Renavotio, Inc. (RIII) , a company that focuses on three unique infrastructure opportunities, including medical protective equipment, utility construction, and utility management, appears to think so, having recently entered into a Stock Purchase Agreement with Tritanium Labs.

Before we dive into Tritanium, let’s introduce Renavotio (RIII) further, a public company which focuses on infrastructure opportunities, including medical protective equipment, 5G, utility construction, utility management, IoT, water, waste management technology, and related industries. The Company's business and acquisition strategy concentrates on medical protective equipment and infrastructure. It engages in utility construction and consulting/operational agreements with small towns or county CO-OPS that operate their own water and sewer systems, providing long-term savings for these municipalities, utilizing smart-utility monitoring, and dedicated engineering and service personnel.

Renavotio’s acquisition of Tritanium provides the Company with a diversified product line to develop a cleaner world. Tritanium's subsidiaries consist of Tritanium Labs, a manufacturer and distributor of the TriCleanz, TruCleanz, and TruSafe brands of sanitizers, disinfectants, sanitizing wipes, and personal protective equipment (PPE). The TriCleanz brand of hand sanitizer is currently available at over 100 Costco Warehouse Clubs and the TruCleanz and TruSafe brands are available at various retailers and sold directly to schools, municipalities, and commercial customers. Since April 2020, Tritanium Labs has sold over 500,000 units of hand sanitizers under the TriCleanz and TruCleanz brands and is currently producing hand sanitizers in 128, 16, 10, and 4-ounce sizes. We love that Tritanium has already sold into big box juggernauts like Costco and to schools and municipalities.

In 2018, Tritanium Labs developed the Tritanium Traceability Blockchain technologies that enable food producers to provide end to end traceability for the ingredients they use and the products they produce. These technologies put Tritanium Labs ahead of the curve in allowing food producer to comply with the FDA’s Food Safety Modernization Act (FSMA) which mandates full traceability by 2024.

Renavotio (RIII) is excited to be nearing completion of its business transformation by building out its three operating divisions: Utility Management & Construction, Infrastructure, and Personal Protective Equipment (PPE) & Medical Manufacturing. The Company strives to develop growth and shareholder value in the coming quarters through its re-branding and new focus.

About The Emerging Markets Report:

The Emerging Markets Report is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing years of experience. Our network consists of stockbrokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets.

For more informative reports such as this, please sign up at http://www.emergingmarketsllc.com/newsletter.php

Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below.

We may purchase Securities of the Profiled Company prior to their securities becoming publicly traded, which we may later sell publicly before, during or after our dissemination of the Information, and make profits therefrom. EMC does not verify or endorse any medical claims for any of its client companies.

EMC has been paid 100,000 restricted shares and $10,000 dollars by Renavotio, Inc. (RIII) for various marketing services including this report. EMC does not independently verify any of the content linked-to from this editorial.

http://emergingmarketsllc.com/disclaimer.php

Emerging Markets Consulting, LLC 
Florida Office
390 North Orange Avenue Suite 2300
Orlando, FL 32801
E-mail: jamespainter@emergingmarketsllc.com
Web: www.emergingmarketsllc.com 

 


Image: EMC logo-black.png

Source: Renavotio Inc. (RIII) and Emerging Markets Consulting, LLC.

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.